Synthesis of platelet-activating factor by human monocytes stimulated by platelet-activating factor

F H Valone1

  • 1Department of Medicine, University of California, San Francisco.

Insights

Platelet-activating factor (PAF) stimulates its own synthesis in human monocytes, prolonging its effects. This self-stimulation, independent of new protein synthesis, may explain sustained inflammatory reactions.

Area of Science:

  • Immunology
  • Biochemistry
  • Cell Biology

Background:

  • Platelet-activating factor (PAF) is a potent lipid mediator involved in inflammation.
  • Understanding the regulation of PAF synthesis is crucial for comprehending inflammatory processes.

Purpose of the Study:

  • To investigate the ability of platelet-activating factor (PAF) to stimulate its own production in human monocytes.
  • To determine the kinetics and regulatory mechanisms of PAF self-synthesis.

Main Methods:

  • Human monocytes were incubated with varying concentrations of PAF and radiolabeled acetic acid.
  • High-performance liquid chromatography (HPLC) was used to purify and quantify newly synthesized PAF.
  • The effect of cycloheximide, a protein synthesis inhibitor, on PAF synthesis was assessed.

Main Results:

  • PAF stimulated its own synthesis in a dose-dependent manner, with maximal effects observed at 10-100 pM.
  • Peak PAF synthesis occurred between 6 and 8 hours of incubation.
  • Delayed PAF synthesis was not inhibited by cycloheximide, suggesting it does not require de novo protein synthesis.

Conclusions:

  • Human monocytes possess the capacity to amplify PAF production in response to PAF.
  • This autocrine stimulation mechanism may contribute to the prolonged half-life of PAF in vivo.
  • The sustained presence of PAF could underlie its role in prolonged inflammatory reactions.